| Dr Jeanne Ruggiero, RN | |
|
400 S Orange Ave, South Orange, NJ 07079-2646 | |
| (973) 761-9272 | |
| Not Available |
| Full Name | Dr Jeanne Ruggiero |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Critical Care Medicine |
| Location | 400 S Orange Ave, South Orange, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922161132 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0200X | Registered Nurse - Critical Care Medicine | 26NC06518600 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeanne Ruggiero, RN 1953 Grenville Rd, Scotch Plains, NJ 07076-2907 Ph: () - | Dr Jeanne Ruggiero, RN 400 S Orange Ave, South Orange, NJ 07079-2646 Ph: (973) 761-9272 |
News Archive
A study published online in a nature journal Scientific Reports suggests that talking in the third person to oneself in stressful times might help controlling emotions and it needs no additional mental effort than first person self-talk, which is normally used by people to talk to themselves.
Active surveillance may be a viable option for some men, but reclassification of disease risk over time is imperative to ensure outcomes, according to researchers in Toronto, who will present these criteria during the 104th Annual Scientific Meeting of the American Urological Association (AUA).
Highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS is the name given to treatment regimens recommended by leading HIV experts to aggressively suppress viral replication and progress of HIV disease. These treatment regimens have been shown to reduce the amount of virus so that it becomes undetectable in a patient's blood.
Despite significant reductions in neonatal mortality previously reported in south Asia, applying a chlorhexidine wash to newborns' umbilical cords in sub-Saharan Africa did not reduce deaths, a study led by researchers from the Boston University School of Public Health shows.
Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.
› Verified 9 days ago
Jane W Maina, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 148 N Wyoming Ave, South Orange, NJ 07079 Phone: 973-275-1725 | |
Ms. Kathleen Joan Mencher, APRN, BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 464 Academy St, South Orange, NJ 07079 Phone: 973-378-8065 Fax: 973-378-8065 | |
Mrs. Pamela Sanbuenaventura, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 293 Melrose Pl, South Orange, NJ 07079 Phone: 646-595-7625 | |
Zelda Rae Patterson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 36 Eder Terrace, South Orange, NJ 07079 Phone: 973-762-7356 |